Biotime

Xiamen Biotime Biotechnology Co., Ltd. is a high-tech enterprise based in the Xiamen Special Economic Zone, established in April 2008. The company specializes in the research, development, production, and sales of point-of-care testing (POCT) in vitro diagnostic (IVD) devices and reagents. With a commitment to global health, Biotime holds over 50 patents and offers a wide range of IVD products across nine series, utilizing various technology platforms such as immunofluorescence, chemiluminescence, and high-performance liquid chromatography. Biotime has demonstrated its rapid development capabilities by creating a COVID-19 test kit in just 25 days and has secured over 20 registration certificates, including FDA Emergency Use Authorization and CE marking. The company operates with a strong in-house R&D team of over 100 engineers and maintains significant manufacturing capacity, producing up to 10 million tests per day. With a global customer base and a mature medical marketing channel, Biotime is dedicated to advancing healthcare diagnostics through innovative solutions and efficient service.

• Employees31
• Founded2008